| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6092710 | Gastroenterology | 2015 | 15 Pages |
Abstract
KIT and KITLG are expressed by a subset of human colon tumors. KIT signaling promotes growth of colon cancer cells and organoids in culture and xenograft tumors in mice via its ligand, KITLG, in an autocrine or paracrine manner. Patients with KIT-expressing colon tumors can benefit from KIT RTK inhibitors.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Evan C. Chen, Taylor A. Karl, Tomer Kalisky, Santosh K. Gupta, Catherine A. O'Brien, Teri A. Longacre, Matt van de Rijn, Stephen R. Quake, Michael F. Clarke, Michael E. Rothenberg,